NasdaqGS - Delayed Quote • USD
Surmodics, Inc. (SRDX)
At close: 4:00 PM EDT
After hours: 4:20 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 3 | 2 |
| Avg. Estimate | -0.32 | -0.32 | -0.94 | -0.29 |
| Low Estimate | -0.36 | -0.36 | -1.03 | -0.77 |
| High Estimate | -0.3 | -0.29 | -0.88 | 0.19 |
| Year Ago EPS | -0.4 | 0.52 | 0.16 | -0.94 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 4 | 3 |
| Avg. Estimate | 28.84M | 29.88M | 119.68M | 136.2M |
| Low Estimate | 28.7M | 29.1M | 118.2M | 128.2M |
| High Estimate | 29.1M | 30.33M | 120.55M | 143.39M |
| Year Ago Sales | -- | -- | 132.58M | 119.68M |
| Sales Growth (year/est) | -- | -- | -9.70% | 13.80% |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | -0.51 | 0.05 | 0.18 | -0.3 |
| EPS Actual | -0.4 | 0.52 | 0.53 | 0 |
| Difference | 0.11 | 0.47 | 0.35 | 0.3 |
| Surprise % | 21.60% | 940.00% | 194.40% | 100.00% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.32 | -0.32 | -0.94 | -0.29 |
| 7 Days Ago | -0.32 | -0.32 | -0.94 | -0.29 |
| 30 Days Ago | -0.32 | -0.32 | -0.94 | -0.29 |
| 60 Days Ago | -0.32 | -0.32 | -0.94 | -0.29 |
| 90 Days Ago | -0.39 | -0.27 | -1.16 | -0.38 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | SRDX | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 20.00% | -- | -- | 6.50% |
| Next Qtr. | -161.50% | -- | -- | 12.00% |
| Current Year | -687.50% | -- | -- | 5.30% |
| Next Year | 69.10% | -- | -- | 13.10% |
| Next 5 Years (per annum) | 10.00% | -- | -- | 11.09% |
| Past 5 Years (per annum) | 44.54% | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Reiterates | Needham: Buy to Buy | 4/10/2024 |
| Maintains | Needham: Buy to Buy | 2/1/2024 |
| Maintains | Barrington Research: Outperform to Outperform | 11/9/2023 |
| Maintains | Needham: Buy to Buy | 11/8/2023 |
| Reiterates | Needham: Buy to Buy | 8/2/2023 |
| Maintains | Barrington Research: Outperform | 6/21/2023 |
Related Tickers
ZIMV ZimVie Inc.
15.82
+2.20%
KIDS OrthoPediatrics Corp.
30.26
+1.07%
VREX Varex Imaging Corporation
16.79
-0.65%
OFIX Orthofix Medical Inc.
12.99
-0.84%
WILYY Demant A/S
22.20
0.00%
CTKB Cytek Biosciences, Inc.
5.76
+2.31%
CVRX CVRx, Inc.
14.69
+2.08%
SILK Silk Road Medical, Inc
17.80
+0.85%
SYK.F Stryker Corporation
312.80
-0.32%
NMRD Nemaura Medical Inc.
0.0542
-4.39%